ArticleInflammatory bowel diseases2024

Solute Transporter OCTN1/Slc22a4 Affects Disease Severity and Response to Infliximab in Experimental Colitis: Role of Gut Microbiota and Immune Modulation.

Federica Del Chierico et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.